Antacon, Miguel A.

HRN: 29-17-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
CEFUROXIME 1.5GM (VIAL)
06/19/2026
06/26/2026
IV
967MG
Q8
T/C RHEUMATIC FEVER
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: